Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sangeeta Verma
Observed name:
Verma, Sangeeta
Institution:
Kurukshetra University
Observed institution:
Kurukshetra University
ORCID:
0000-0001-9729-5818
Observed ORCID:
0000-0001-9729-5818
OpenAlex ID:
A5060142238
Quinoline Hydrazide/Hydrazone Derivatives: Recent Insights on Antibacterial Activity and Mechanism of Action
2023
·
Sangeeta Verma
, Sukhbir Lal
, et al.
·
ChemMedChem
·
94
Recent insights into antibacterial potential of benzothiazole derivatives
2023
·
Priyanka Kashyap
, Sangeeta Verma
, et al.
·
Medicinal Chemistry Research
·
43
PDF
Recent developments of the β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors: Emerging indication as antibacterial agents
2025
·
Sangeeta Verma
, Pankaj Gupta
, et al.
·
European Journal of Medicinal Chemistry
·
9
Expanding potential of quinoline hydrazide/hydrazone derivatives as anticancer agents
2024
·
Sangeeta Verma
, Sukhbir Lal
, et al.
·
Future Medicinal Chemistry
·
9
PDF
Tubulin inhibitors: an insight into new strategies to combat leukemia
2025
·
Sangeeta Verma
, Pankaj Gupta
, et al.
·
Future Medicinal Chemistry
·
3
Quinoline Heterocyclic Clubbed Hydrazone Derivatives as Potential Inhibitors of Mutant S. aureus DNA Gyrase A; An In Silico Drug Discovery Approach -Molecular Docking, MD Simulation, DFT Analysis and ADMET Predictions
2025
·
Sangeeta Verma
, Sukhbir Lal
, et al.
·
Current Medicinal Chemistry
·
3
Design, Synthesis, Antimicrobial, and Antimalarial Evaluation of Quinoline Hydrazone Derivatives: Insight through Density Functional Theory Analysis, Molecular Docking, and Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictions
2025
·
Sangeeta Verma
, Sukhbir Lal
, et al.
·
ChemMedChem
·
3
Recent Insights into Osimertinib Analogues against EGFR Positive Non-small Cell Lung Cancer
2023
·
Jatin Chhabra
, Priyanka Kashyap
, et al.
·
Current Topics in Medicinal Chemistry
·
1
Show more works
View as search
Works count:
10
Citation count:
165
H-index:
4
I10-index:
2
Year
Topic
Type